title: Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
authors.affiliation: The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.|The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.|SC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
authors.affiliation: Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Berger
authors.affiliation: Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.affiliation: Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Carson
authors.affiliation: The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.|The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.|SC Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.|Oncology Analytics Inc, Plantation, FL, USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Hrushesky
authors.affiliation: The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.|The Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Georgantopoulos
authors.affiliation: College of Pharmacy, Pharmacoeconomics, Epidemiology, Public Policy, Outcomes Research Program, University of New Mexico, Albuquerque, NM, USA.
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Raisch
authors.affiliation: The Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.
authors.forename: LeAnn B
authors.initials: LB
authors.lastname: Norris
authors.affiliation: The University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: James O
authors.initials: JO
authors.lastname: Armitage
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis* / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine
keywords: chronic lymphyocytic leukaemia; ibrutinib; progressive multifocal leucoencephalopathy